Vega Migraine

Free

4.5for iPhone

Eli Lilly and Company

Developer

Jun 9, 2022

Update Date

Health & Fitness

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Vega Migraine Screenshots

iPhone

About Vega Migraine

The Vega Migraine app is used to log migraine information and share that information with your doctor. At this time, Vega requires a registration code, provided by a healthcare provider, to access app functionality. Registration codes can be found in the onboarding materials provided by your healthcare provider. You may use code 482579 to register if you have not received a code from your healthcare provider.

Note: Vega is not intended to provide diagnostic and/or treatment decisions, or replace the care and advice of a licensed healthcare provider. All medical analysis and treatment plans should be performed by a licensed healthcare provider.

Vega optionally integrates with Apple Health. Here are the attributes that may enable users to integrate with their Vega data:
Menstruation
Activity (steps, workout)

These may be used with other potential triggers to explore and compare with previously recorded migraine days and medication administrations.

PP-VG-US-0031 02/2022